Astrabio
Latest round
- Series B
Last raised
- Sep 2026
Total raised
- $22M
Investors
- 5
About Astrabio
, trading as Astrabio, operates as a diagnostic equipment developer that focuses on single-molecule immunodiagnostic technology. The company also established an 8000-square meter of research and development and production centre. It has applied for more than 40 patents and has passed ISO 13485:2016 Medical Device Quality Management System Certification. In November 2022, the fully automated single molecule immunoassay analyzer developed by the company has entered into the application process for registration of innovative products for medical devices. The company primarily engages in the research, development, production, and sales of next-generation immunodiagnostic equipment and reagents. Its main products include the AST-Sc-Ulti ultrasensitive single-molecule immunoassay analyzer and the AST-Dx90 single-molecule immunodiagnostic analyzer. The company generates revenue by developing, manufacturing, and selling immunodiagnostic instruments, diagnostic reagents, and related testing solutions and services. Simultaneously, the company is accelerating the construction of its global commercialization network and overseas product registration, enhancing the international market competitiveness of domestically produced neurodiagnostic products, and steadily promoting the globalization of Chinese neurodiagnostic brands.
Who invested in Astrabio
5 investors across 2 rounds
See all investors in Astrabio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Astrabio
Who invested in Astrabio?
Astrabio has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Astrabio raised?
Astrabio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Astrabio last raise money?
Astrabio's most recent round on record is a Series B, in Sep 2026.
What does Astrabio do?
, trading as Astrabio, operates as a diagnostic equipment developer that focuses on single-molecule immunodiagnostic technology.
Where is Astrabio headquartered?
Astrabio is headquartered in Suzhou, China.
Which VCs invest in companies like Astrabio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Astrabio's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Astrabio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.